Newsroom | 3962 results

ZURICH--(BUSINESS WIRE)--CDR-Life today announced the presentation of data for its novel T cell engager (TCE) programs at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago. The presentations showcase the company's proprietary M-gager® platform-derived TCE candidates, with a focus on CDR404, currently in Phase 1 clinical trials for MAGE-A4-positive solid tumors. “The data presented at AACR highlight the potential advantages of our antibody-based approach to T cel...

LOS ANGELES--(BUSINESS WIRE)--It’s no secret that our waistlines often expand in middle-age, but the problem isn’t strictly cosmetic. Belly fat accelerates aging and slows down metabolism, increasing our risk for developing diabetes, heart problems and other chronic diseases. Exactly how age transforms a six pack into a softer stomach, however, is murky. Now preclinical research by City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United Stat...

DURHAM, N.C. & MÄNNEDORF, Switzerland--(BUSINESS WIRE)--BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of hundreds to thousands of individual cells, addressing growing demand for scalable, multiomi...

BERKELEY, Calif.--(BUSINESS WIRE)--Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of its manufacturing-grade IsoTag™ AAV reagent for the purification of Adeno-associated Virus (AAV) vectors. As indicated during the launch of the research-grade reagent in October 2024, this final advancement in product grade now includes production with validated processes and the availability of a full suite of documentation, including a...

TOKYO--(BUSINESS WIRE)--U-Factor Co., Ltd. (“U-Factor”) is pleased to announce that partner Hitonowa Medical Clinic has received the “Excellence Award” at the 24th Congress of the Japanese Society for Regenerative Medicine for pioneering research on amyotrophic lateral sclerosis (ALS). This milestone in regenerative medicine provides strong momentum for both organizations’ joint research and business development. Research Overview Background: A retrospective cohort study was conducted from Janu...

AUSTIN, Texas--(BUSINESS WIRE)--Gameto Announces First U.S. Clinical Site Open for Enrollment in Fertilo Study...

LAUSANNE, Schweiz--(BUSINESS WIRE)--Debiopharm (www.debiopharm.com), ein privat geführtes Schweizer Biopharmaunternehmen, das sich zum Ziel gesetzt hat, neue Standards in der Behandlung von Krebs und Infektionskrankheiten zu etablieren und neue Antikörper-Linker-Technologien zu entwickeln, wird auf der Jahreskonferenz 2025 der American Association for Cancer Research (AACR) in Chicago, Illinois, vielversprechende neue Daten zu zwei seiner Pipeline-Produkte veröffentlichen. Darüber hinaus wird i...

LOSANNA, Svizzera--(BUSINESS WIRE)--  Debiopharm presenterà dati approfonditi ottenuti con la sua ricerca sui coniugati anticorpo-farmaco (ADC), sugli inibitori della risposta ai danni del DNA (DDR) e sulla tecnologia di coniugazione anticorpale in occasione del convegno AACR 2025 a Chicago   Debiopharm (www.debiopharm.com), una società biofarmaceutica svizzera di proprietà privata che mira a definire lo standard di cura del futuro per il trattamento dei tumori e di malattie infettive nonché a...

BARCELLONA, Spagna--(BUSINESS WIRE)--Dal 24 al 26 aprile, Barcellona ospiterà l'11a edizione del congresso internazionale di IVIRMA, per importanza il terzo congresso al mondo in materia di dimensioni e diffusione scientifica nel campo della riproduzione umana assistita. L'evento, organizzato da IVIRMA Global, richiamerà esperti internazionali nel settore della fertilità, dell'embriologia, della genetica riproduttiva e dell'AI applicata alla riproduzione umana. Il congresso si svolge in un cont...